HIK.L
Hikma Pharmaceuticals PLC
Price:  
1,956.00 
GBP
Volume:  
978,995.00
United Kingdom | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HIK.L WACC - Weighted Average Cost of Capital

The WACC of Hikma Pharmaceuticals PLC (HIK.L) is 9.0%.

The Cost of Equity of Hikma Pharmaceuticals PLC (HIK.L) is 10.00%.
The Cost of Debt of Hikma Pharmaceuticals PLC (HIK.L) is 5.65%.

Range Selected
Cost of equity 8.80% - 11.20% 10.00%
Tax rate 20.90% - 22.90% 21.90%
Cost of debt 4.90% - 6.40% 5.65%
WACC 7.9% - 10.1% 9.0%
WACC

HIK.L WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 6.0% 7.0%
Adjusted beta 0.8 0.89
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.80% 11.20%
Tax rate 20.90% 22.90%
Debt/Equity ratio 0.22 0.22
Cost of debt 4.90% 6.40%
After-tax WACC 7.9% 10.1%
Selected WACC 9.0%